Novartis chief sees possibility of a U.S. flu-vaccine plant
3rd Nov 2005, 15:14 GMT
The chief executive of the Swiss drug company Novartis has said that his company would consider building a vaccine-production plant in the United States, amid concern that a planned acquisition would make Washington even more reliant on foreign sources for flu vaccine.
Novartis chief sees possibility of a U.S. flu-vaccine plant related news:
- Novartis May Build U.S. Flu Vaccine Plant — Rednova News - Health
- Novartis Would Consider U.S. Vaccine Plant, Chief Says — NYT > Business
- Bush's Flu Plan Stresses Vaccine — orlandosentinel.com headlines
- Bush's Flu Plan Stresses Vaccine. — Environmental Health News
- Bush's Flu Plan Stresses Vaccine (Los Angeles Times) — Yahoo! News: Top Stories
- Novartis Seeks Government Help on Vaccines — WSJ.com: What's News Europe
- Chiron to be bought by Swiss drug giant — News -- SiliconValley.com
- Vaccines Plant is to Change Hands Again — Rednova News - Health
- Bird flu: Bush plan would take five years — The Seattle Times: Health
- Novartis considers building in U.S. — World News - Europe - International Herald Tribune
Latest news from World News - Americas - International Herald Tribune:
- A 'new' Democrat with an old-fashioned flair
- Seoul balks at U.S. plan to enforce naval ban
- Foreign students resume influx at U.S. colleges
- Post-election Congress has a long to-do list
- California is ready to reap rewards of Democrats' victory
- Airbus crash issues linger in U.S.
- Hospitals aim to give faster care
- Hamas and Fatah back leader for new Palestinian government
- Brazil 'rubber soldiers' fight for recognition
- Republican losses are California's gain